US Patent 7687509 Pyrimidinecarboxamide derivatives
Patent 7687509 was granted and assigned to Concert Pharmaceuticals on March, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2023
Golden AI
Edits made to:
Article (+314 characters)
Article
Patent abstract
This disclosure relates to novel HIV integrase inhibitors their derivatives, pharmaceutically acceptable salts, solvates, and hydrates thereof. This disclosure also provides compositions comprising a compound of this disclosure and the use of such compositions in methods of treating HIV infections.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07687509 Pyrimidinecarboxamide derivatives US Patent 7687509 Pyrimidinecarboxamide derivatives
Infobox
Patent Number
0768750900
Patent Number
768750900
Edits on 30 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076875090
Date of Patent
March 30, 2010
0Patent Application Number
121693670
Date Filed
July 8, 2008
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076875090
Date of Patent
March 30, 2010
0Patent Application Number
121693670
Date Filed
July 8, 2008
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07687509 Pyrimidinecarboxamide derivatives
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07687509
Date of patent
March 30, 2010
Patent application number
12169367
Date Filed
July 8, 2008
Patent primary examiner
Find more entities like US Patent 7687509 Pyrimidinecarboxamide derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
